Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000385 · ClinicalTrials.gov registry record · Phase 3
Long-Term Lithium Treatment for Aggressive Conduct Disorder
A Phase 3 study, sponsored by Drexel University.
- Completed
- Registry status
- Phase 3
- Development phase
- 59
- Enrollment target
NCT00000385: Completed Phase 3 study, sponsored by Drexel University.
NCT00000385 is a Phase 3 study that has completed, run by Drexel University. The registered enrollment target is 59 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000385, a Phase 3 study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 59 participants
- Enrollment target
Study Summary
This study will examine the long-term effects of lithium used to treat children and adolescents with aggressive conduct disorder (severe aggression).
Interventions
- DRUG Placebo
- DRUG Lithium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 1997-09 |
| Est. Completion | 2005-06 |
| Phase | Phase 3 |
What the finished NCT00000385 record still lists
NCT00000385 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00000385 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000385 about?
NCT00000385 is a clinical study titled "Long-Term Lithium Treatment for Aggressive Conduct Disorder". This study will examine the long-term effects of lithium used to treat children and adolescents with aggressive conduct disorder (severe aggression).
What is the current status of trial NCT00000385?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 59 participants. The study started on 1997-09. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00000385?
The interventions under investigation include: Placebo (DRUG), Lithium (DRUG).
Who is sponsoring clinical trial NCT00000385?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000385's enrollment target sits among peer trials
59 1824th of 2000 higher than 176 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia